Literature DB >> 23641799

Magnetic and photoresponsive theranosomes: translating cell-released vesicles into smart nanovectors for cancer therapy.

Amanda K A Silva1, Jelena Kolosnjaj-Tabi, Stephanie Bonneau, Iris Marangon, Nicole Boggetto, Kelly Aubertin, Olivier Clément, Michel Francis Bureau, Nathalie Luciani, Florence Gazeau, Claire Wilhelm.   

Abstract

Cell-released vesicles are natural carriers that circulate in body fluids and transport biological agents to distal cells. As nature uses vesicles in cell communication to promote tumor progression, we propose to harness their unique properties and exploit these biogenic carriers as Trojan horses to deliver therapeutic payloads to cancer cells. In a theranostic approach, cell-released vesicles were engineered by a top-down procedure from precursor cells, previously loaded with a photosensitizer and magnetic nanoparticles. The double exogenous cargo provided vesicles with magnetic and optical responsiveness allowing therapeutic and imaging functions. This new class of cell-derived smart nanovectors was named "theranosomes". Theranosomes enabled efficient photodynamic tumor therapy in a murine cancer model in vivo. Moreover the distribution of this biogenic vector could be monitored by dual-mode imaging, combining fluorescence and MRI. This study reports the first success in translating a cell communication mediator into a smart theranostic nanovector.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23641799     DOI: 10.1021/nn400269x

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  24 in total

1.  Liposome-like Nanostructures for Drug Delivery.

Authors:  Weiwei Gao; Che-Ming J Hu; Ronnie H Fang; Liangfang Zhang
Journal:  J Mater Chem B       Date:  2013-12-28       Impact factor: 6.331

Review 2.  Re-Engineering Extracellular Vesicles as Smart Nanoscale Therapeutics.

Authors:  James P K Armstrong; Margaret N Holme; Molly M Stevens
Journal:  ACS Nano       Date:  2017-01-09       Impact factor: 15.881

3.  Dynamic biodistribution of extracellular vesicles in vivo using a multimodal imaging reporter.

Authors:  Bakhos A Tannous; Xandra O Breakefield; Charles P Lai; Osama Mardini; Maria Ericsson; Shilpa Prabhakar; Casey Maguire; John W Chen
Journal:  ACS Nano       Date:  2014-01-09       Impact factor: 15.881

Review 4.  New photosensitizers for photodynamic therapy.

Authors:  Heidi Abrahamse; Michael R Hamblin
Journal:  Biochem J       Date:  2016-02-15       Impact factor: 3.857

5.  Super-Resolution Imaging of Intracellular Lipid Nanocarriers to Study Drug Delivery in Photodynamic Therapy.

Authors:  Enzo M Scutigliani; Jakub A Kochan; Emilie C B Desclos; Art Jonker; Michal Heger; Przemek M Krawczyk
Journal:  Methods Mol Biol       Date:  2022

Review 6.  Microparticles: biogenesis, characteristics and intervention therapy for cancers in preclinical and clinical research.

Authors:  Yan Hu; Yajie Sun; Chao Wan; Xiaomeng Dai; Shuhui Wu; Pui-Chi Lo; Jing Huang; Jonathan F Lovell; Honglin Jin; Kunyu Yang
Journal:  J Nanobiotechnology       Date:  2022-04-13       Impact factor: 10.435

7.  Visualization and tracking of tumour extracellular vesicle delivery and RNA translation using multiplexed reporters.

Authors:  Charles P Lai; Edward Y Kim; Christian E Badr; Ralph Weissleder; Thorsten R Mempel; Bakhos A Tannous; Xandra O Breakefield
Journal:  Nat Commun       Date:  2015-05-13       Impact factor: 14.919

Review 8.  Strategic design of extracellular vesicle drug delivery systems.

Authors:  James P K Armstrong; Molly M Stevens
Journal:  Adv Drug Deliv Rev       Date:  2018-06-28       Impact factor: 15.470

Review 9.  Photosensitizers in prostate cancer therapy.

Authors:  Taher Gheewala; Troy Skwor; Gnanasekar Munirathinam
Journal:  Oncotarget       Date:  2017-05-02

10.  Isolated cell-bound membrane vesicles (CBMVs) as a novel class of drug nanocarriers.

Authors:  Yang Zhang; Yang Liu; Wendiao Zhang; Qisheng Tang; Yun Zhou; Yuanfang Li; Tong Rong; Huaying Wang; Yong Chen
Journal:  J Nanobiotechnology       Date:  2020-05-06       Impact factor: 10.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.